Skip to main content
Livermore
Livermore
ZHEN

Redmile Group, LLC

SEC CIK
0001425738
Latest filing
Aug 14, 2026

Holdings in Q4 2023

Holdings as of Dec 31, 2023, filed Feb 14, 2024. Long positions only; changes compare share counts with Q3 2023.

Institution overview
Positions
70
+2 vs. Q3 2023
Portfolio value
$2.80B
+$694.2M (+33.0%) vs. Q3 2023
Filed
Feb 14, 2024
SEC
Holdings of Redmile Group, LLC in Q4 2023
SecurityClassSharesValue% of portfolioShare changeActionHistory
BCELAtreca, Inc.CL A COM442,653$58.4K<0.1%00.0%UnchangedHistory
VTYXVentyx Biosciences, Inc.COM207,203$511.8K<0.1%−722,697−77.7%ReducedHistory
ADAPYAdaptimmune Therapeutics PLCSPONDS ADR715,607$567.5K<0.1%00.0%UnchangedHistory
TKNOAlpha Teknova, Inc.COM161,005$600.5K<0.1%−123,559−43.4%ReducedHistory
HOOKHOOKIPA Pharma Inc.COM1,063,769$861.7K<0.1%00.0%UnchangedHistory
NVTAInvitae CorpCOM1,474,026$923.9K<0.1%−806,377−35.4%ReducedHistory
SLGCSomaLogic, Inc.CLASS A COM370,839$938.2K<0.1%−28,600−7.2%ReducedHistory
KLRSKalaris Therapeutics, Inc.COM1,907,969$1.30M<0.1%00.0%UnchangedHistory
Achilles Therapeutics PLC00449L102SPONSORED ADS1,608,089$1.43M0.1%00.0%Unchanged–
XERSXeris Biopharma Holdings, Inc.COM1,046,587$2.46M0.1%00.0%UnchangedHistory
MDVLMedAvail Holdings, Inc.COM NEW692,082$3.05M0.1%00.0%UnchangedHistory
LVTXLAVA Therapeutics NVSHS2,074,372$3.28M0.1%00.0%UnchangedHistory
NUVBNuvation Bio Inc.COM CL A3,031,009$4.58M0.2%00.0%UnchangedHistory
ATRAAtara Biotherapeutics, Inc.COM9,106,446$4.67M0.2%+2,825,633+45.0%AddedHistory
SNCEScience 37 Holdings, Inc.COM NEW990,412$5.29M0.2%00.0%UnchangedConverted for a 1-for-20 splitHistory
IVVDInvivyd, Inc.COM1,440,725$5.68M0.2%00.0%UnchangedHistory
STXSStereotaxis, Inc.COM NEW3,402,443$5.95M0.2%−2,363,349−41.0%ReducedHistory
RAPTRAPT Therapeutics, Inc.COM366,776$9.11M0.3%−60,714−14.2%ReducedHistory
ACIUAC Immune SASHS2,000,000$10.0M0.4%+2,000,000NewHistory
ALLKAllakos Inc.COM3,670,447$10.0M0.4%−464,614−11.2%ReducedHistory
ELVElevance Health, Inc.Stock23,079$10.9M0.4%−62,299−73.0%ReducedHistory
PRMEPrime Medicine, Inc.COM1,324,350$11.7M0.4%00.0%UnchangedHistory
GRTSGritstone bio, Inc.COM5,872,605$12.0M0.4%−2,636,521−31.0%ReducedHistory
ALGNAlign Technology IncCOM50,082$13.7M0.5%+50,082NewHistory
STOKStoke Therapeutics, Inc.COM2,625,506$13.8M0.5%−1,247,190−32.2%ReducedHistory
RPTXRepare Therapeutics Inc.COM2,148,748$15.7M0.6%−255,947−10.6%ReducedHistory
SYKStryker CorpStock53,141$15.9M0.6%−41,597−43.9%ReducedHistory
COGTCogent Biosciences, Inc.COM2,914,022$17.1M0.6%+860,689+41.9%AddedHistory
HCAHCA Healthcare, Inc.COM66,100$17.9M0.6%+41,433+168.0%AddedHistory
ISRGIntuitive Surgical IncCOM NEW54,258$18.3M0.7%+54,258NewHistory
NGNENeurogene Inc.COM946,897$18.4M0.7%+801,286+550.3%AddedConverted for a 1-for-4 splitHistory
TRDAEntrada Therapeutics, Inc.COM1,283,735$19.4M0.7%−2650.0%ReducedHistory
CRLCharles River Laboratories International, Inc.COM86,782$20.5M0.7%+20,400+30.7%AddedHistory
ETNB89bio, Inc.COM1,969,402$22.0M0.8%+1,207,447+158.5%AddedHistory
PENPenumbra IncCOM95,242$24.0M0.9%−59,834−38.6%ReducedHistory
VERVVerve Therapeutics, Inc.COM1,718,669$24.0M0.9%+908,892+112.2%AddedHistory
IGMSIGM Biosciences, Inc.COM2,971,542$24.7M0.9%00.0%UnchangedHistory
ANNXAnnexon, Inc.COM5,503,190$25.0M0.9%+2,000,000+57.1%AddedHistory
ADCTADC Therapeutics SASHS15,328,317$25.4M0.9%+1,150,272+8.1%AddedHistory
AKROAkero Therapeutics, Inc.COM1,109,476$25.9M0.9%−660,208−37.3%ReducedHistory
EVHEvolent Health, Inc.CL A835,537$27.6M1.0%+370,255+79.6%AddedHistory
ABTAbbott LaboratoriesStock265,500$29.2M1.0%+265,500NewHistory
CABACabaletta Bio, Inc.COM1,374,189$31.2M1.1%−400,063−22.5%ReducedHistory
REPLReplimune Group, Inc.COM3,865,258$32.6M1.2%−298,664−7.2%ReducedHistory
IDYAIDEAYA Biosciences, Inc.COM935,863$33.3M1.2%+935,863NewHistory
NRIXNurix Therapeutics, Inc.COM3,256,519$33.6M1.2%+407,692+14.3%AddedHistory
ABSIAbsci CorpCOM8,031,094$33.7M1.2%00.0%UnchangedHistory
BEAMBeam Therapeutics Inc.COM1,429,783$38.9M1.4%−39,942−2.7%ReducedHistory
CLDXCelldex Therapeutics, Inc.COM NEW993,803$39.4M1.4%−642,135−39.3%ReducedHistory
STTKShattuck Labs, Inc.COM5,619,914$40.1M1.4%00.0%UnchangedHistory
BSXBoston Scientific CorpStock693,200$40.1M1.4%−81,000−10.5%ReducedHistory
IMVTImmunovant, Inc.COM977,072$41.2M1.5%−125,442−11.4%ReducedHistory
IMNMImmunome Inc.COM3,879,415$41.5M1.5%+3,879,415NewHistory
KYMRKymera Therapeutics, Inc.COM1,823,956$46.4M1.7%−44,551−2.4%ReducedHistory
PLRXPliant Therapeutics, Inc.COM2,696,648$48.8M1.7%+18,549+0.7%AddedHistory
FATEFate Therapeutics IncCOM13,169,057$49.3M1.8%+44,630+0.3%AddedHistory
CTLTCatalent, Inc.COM1,100,466$49.4M1.8%+226,500+25.9%AddedHistory
ALXOAlx Oncology Holdings IncCOM3,659,264$54.5M1.9%+2,375,975+185.1%AddedHistory
LIVNLivaNova PLCSHS1,137,068$58.8M2.1%+36,576+3.3%AddedHistory
ZYMEZymeworks Inc.COM5,790,230$60.2M2.2%+129,000+2.3%AddedHistory
BHVNBiohaven Ltd.COM1,444,365$61.8M2.2%+925,441+178.3%AddedHistory
RGNXREGENXBIO Inc.COM3,760,690$67.5M2.4%+1,186,648+46.1%AddedHistory
SPYSPDR S&P 500 ETF TrustETF142,500$67.7M2.4%+142,500NewHistory
DCPHDeciphera Pharmaceuticals, Inc.COM4,801,540$77.4M2.8%+326,156+7.3%AddedHistory
AUGXAugmedix, Inc.COM16,380,327$95.8M3.4%+750,000+4.8%AddedHistory
RYZBRayzeBio, Inc.COM1,857,706$115.5M4.1%00.0%UnchangedHistory
SRRKScholar Rock Holding CorpCOM6,402,505$120.4M4.3%+1,669,257+35.3%AddedHistory
FOLDAmicus Therapeutics, Inc.COM14,828,321$210.4M7.5%−2,116,300−12.5%ReducedHistory
KRYSKrystal Biotech, Inc.COM1,733,189$215.0M7.7%−270,178−13.5%ReducedHistory
IMGNImmunoGen, Inc.COM16,423,922$487.0M17.4%−1,079,495−6.2%ReducedHistory

Sold out since Q3 2023 (5)

Positions held at the end of Q3 2023 that are gone from this filing.

Positions of Redmile Group, LLC sold out since Q3 2023
SecurityClassShares in Q3 2023Value in Q3 2023% of portfolio in Q3 2023History
HUMHumana IncStock59,851$29.1M1.4%History
DXCMDexcom IncCOM244,391$22.8M1.1%History
XENEXenon Pharmaceuticals Inc.COM419,568$14.3M0.7%History
CUTRCutera IncCOM334,996$2.02M0.1%History
SONXSonendo, Inc.COM410,393$306.1K<0.1%History